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Composition of hemodialysate. N. D. Burman, Renal Unit, Tyger-
berg Hospital, Cape Town. Variation of hemodialysate to Suit each
patient outside large dialysis units is expensive in terms of mixing,
monitoring, and water purifying equipment, technical expertise,
and the wide range of concentrates needed to cater for all possi-
bilities. Analysis of domestic water supplies in Southern Africa
shows gross area differences in water purity, as well as a wide
seasonal suring—particularly of calcium and magnesium content.
A rapidly expanding community dialysis program in times of 6-
nancial restriction demands simplicity and standardization. A
basic chronic hemodialysate concentrate is proposed for use with
hand-mixed tank dialyzers and water softeners to give a final
hemodialysate with sodium, 138; potassium, 1.6; calcium, 1.75;
magnesium, 0; chloride, 105; glucose, 0; and acetate * 36
mmoles/liter.
Acute renal failure during magnesium-potassium depletion cancer
therapy. N. D. Burman. Renal Unit, Tygerberg Hospital, Cape
Town. Dietary and dialysis-induced magnesium-potassium deple-
tion has produced significant cancer regression with a remarkable
absence of systemic side effects. Paradoxically, during trials two
patients developed reversible acute renal failure (ARF). A patient
with depletion-induced necrosis of a bronchial carcinoma had a
mildly raised serum carcino-embryonic antigen (CEA) titre, and a
transient immune complex nephritis on serial biopsies. In the sec-
ond patient, induced necrosis of breast metastases, was associated
with ARF with raised serum CEA, 1gM and circulating antibodies
to renal and hepatic reticulum and renal tubular cytoplasm. Serum
levels of antireticulum antibodies, C3, and 1gM rose repeatedly
with reactivation of her tumor. Renal biopsies and autopsy were
refused. Both patients thus apparently had ARF due to tumor
necrosis-associated immune complex nephritis and antitubular an-
tibodies.
Common glomerular disease in African children in Durban. H. M.
('oovadia and D. Adhikari. Department of Paediatrics and Child
Health, Durban. Acute glomerulonephritis and the nephrotic syn-
drome are the most common glomerular diseases seen in African
children in Durban. Results of a prospective study of the clinical,
biochemical, etiologic, immunologic, and histological parameters
of acute glomerulonephritis in 28 African children are presented.
The findings generally confirm that the above features are in com-
mon with reports of this disease from other parts of the world. In
contrast there is a striking difference in the frequency of the histo-
logic types of the nephrotic syndrome in African children. The
clinical, biochemical, histologic and immunofluorescent patterns
of 80 children are discussed. Brief mention is made of the therapy
and follow-up of these patients.
A case of "Wegener's syndrome" associated with rapidly progres-
sive glomerulonephritis. P. Disler, J. Mime, D. Salant. J. Lewin, and
A. Meyers. Renol Unit, Johannesburg General Hospital, Johannes-
burg. A patient with long standing nasal disease, recent nasal
septum perforation, and deafness developed progressive renal fail-
ure over an interval of one week. Concomitant with the renal
failure, he developed a hemorrhagic rash, polyarthritis, pen-
carditis, and myocarditis. On chest X-ray, bilateral apical rounded
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opacties were seen. Renal biopsy performed within two weeks of
the renal failure showed 100% circumferential crescents with mild
glomerular necrosis, mild neutrophil infiltration and fibrosis, but
no vasculitis. The immunofluorescent findings revealed heavy gb-
merular deposits of 1gM, IgA, and C3 and a small amount of lgG
and fibrinogen. He was initially maintained on peritoneal dialysis,
prednisolone, cyclophosphamide, persantin, and heparin and is
currently showing some return of renal function independent of
dialysis.
Maintenance dialysis and renal transplantation facilities in South
Africa, July, 1976. K. I. Furman. University of the Wit watersrand
and Renal Unit, Johannesburg Hospital. A survey undertaken at the
end of July, 1976, revealed that 22 hospital centers were maintaining
a total of 258 chronic renal failure patients by hemodialysis and 32
patients by peritoneal dialysis. In addition, 8 patients were receiv-
ing home dialysis. Five of the centers that had transplantation
programs were treating 224 survivors with functioning renal homo-
grafts. The patients in the different racial groups on treatment are
shown in the following table:
Whites
Blacks
Coloured
Asiatics
National
total
4.24 197 194 391
17.70 55 6 61
2.37 38 19
0.73 8 5
25.04 298 224 522
Use of cimetidine in anephric man. M. C. Gregory. Renal Unit,
Groote Schuur Hospital, Cape Town. Cimetidine, which blocks
gastric H2 receptors, is an effective antagonist of gastric acid secre-
tion in man. It is believed to be excreted largely by the kidneys, but
little is known about its safety in uremia. It is potentially a most
useful drug in renal failure, a condition in which hypergastrinemia
and peptic ulceration are common. Intravenous doses of 125mg of
cimetidine were given to a 26 yr old patient whose sole kidney, a
recent transplant, had been removed five days previously on ac-
count of recurrent duodenal perforation. Cimetidine suppressed
gastric acid secretion and elevated intragastric pH for 2 to 5 hr
after each dose. This is a similar response to that seen in normal
man. Measured plasma half-life of cimetidine was 87 minutes: this
was shortened to 56 minutes while the patient was being hemo-
dialysed. Dialysis immediately after a dose of cimetidine did not
appear to shorten its action. Dyspeptic symptoms were abolished,
and neither duodenal perforation nor overt gastrointestinal bleed-
ing recurred. A total dose of 1.5 g of cimetidine was given over
three days, and no toxic effects were observed.
Renal amyloid associated with tuberculosis. D. Jag/ivan. Liv-
ingstone Hospital, Port Elizabeth. Secondary renal amyloid follow-
ing pulmonary tuberculosis is a rarely reported disease in South
Africa. Four cases of histologically proven renal amyloidosis asso-
ciated with active pulmonary tuberculosis are presented, all of
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whom manifested the nephrotic syndrome after institutional treat-
ment of their tuberculosis. The average age of the patients was
35 yr; the average duration of the antecedent pulmonary tubercu-
losis was 5.6 yr, and the average duration of the nephrotic syn-
drome was 15.8 months. One patient is alive 18 months after
diagnosis; the duration of the antecedent tuberculosis is four years.
A second patient, an African male, aged 29 yr, died in renal failure
29 months after the onset of the nephrotic syndrome, and who at
necropsy had evidence of gross renal amyloid and chronic pul-
monary thromboembolism. Two patients presented with estab-
lished renal failure and died within ten days of admission. Both
complained of severe abdominal pain prior to death, became hypo-
tensive and oliguric. A necropsy diagnosis of renal amyloid was
made.
Retrospective study of "chronic pyelonephritis." G. R. Keeton and
A. Cavadas. Somerset Hospital, Cape Town. To assess the problem
of "chronic pyelonephritis" in Cape Town, patient records at the
New Somerset Hospital and Groote Schuur Hospital for the pe-
riod 1971 to 1974 were analyzed. Fifty-one patients were included
on clinical, radiological, urinary, and macroscopic post mortem
criteria. These patients were divided into four subgroups com-
prising 25 patients with chronic pyelonephritis, 10 diabetic patients
with papillary necrosis, 8 patients with reflux pyelonephritis, and 8
patients with analgesic nephropathies. The 25 patients with chronic
pyelonephritis were further subdivided into the following four
groups: six patients with post mortem diagnosis of pyelonephritis,
five of whom died from septicaemia; ten in advanced renal failure; six
presenting with an acute pyelonephritic episode and having a clas-
sical excretory urogram; and three patients with the classical ex-
cretory urogram of pyelonephritis but presenting with other sys-
temic disease. The associated factors in 16 patients dying and in
advanced renal failure were hypertension, recurrent urinary tract
infection, Onset of pyelonephritis in pregnancy, gout, mild diabetes,
and gross debility and alcoholism. The eight in the refiux pyelo-
nephritic group were younger, and five had recurrent acute pyelo-
nephritis. The ten diabetic patients were elderly and presented with
fulminant septicemia, five patients dying during such episodes. Six
of the eight analgesic nephropathies had recurrent acute pyelo-
nephritis. We conclude that progressive renal failure is unrelated to
the classical urographic appearance of pyelonephritis. Furthermore,
we do not believe that the associated factors, as described, are
necessarily causative in progressive loss of renal function. It is
possible that a progressive interstitial nephritis may be induced by
undetected drug ingestion or other as yet undefined etiologic fac-
tors.
Nutritional status of the Johannesburg chronic hemodialysis
(CHD) patients. D. Lazic, L. Szabunia, J. Mi/ne, R. Shires,
V. Jennings, and A. Meyers. Renal Unit, Johannesburg General
Hospital. A study was made of 27 CHD patients (9 female, 17
male) in order to investigate their nutritional Status and the nutri-
tional adequacy of their diets. The mean duration on dialysis for
the females was 29 months (range, 5 to 84) and for the males, 30
months (range, 4 to 84). Three-day dietary records were taken and
these were checked for reliability against dietary history patterns.
Dietary data was analyzed using United States Department of
Agriculture Food Composition Tables, In order to evaluate their
nutritional status, a clinical assessment of estimated dry body wt
(EDW) was made. Biochemical (serum albumen and transferrin)
and skinfold (triceps and subcapular) measurements (Lange cali-
per) were done. Caloric intake was below the recommended 35 to
50 Kcals/kg of body wt per EDW in 4 females and 16 males. It was
below this intake in 8 females and 15 males when the desired body
wt (DBW) was considered. The DBW was derived from the Metro-
politan Life Insurance Tables. Although 5 females and 10 males
consumed adequate total protein (at least 1 g/kg of body wt per
day), only 2 females and 6 males consumed the recommended 0.8 g
high biological value protein/kg/day. Skinfold measurements and
comparison of EDW with DBW indicated a marked state of under-
nutrition particularly among the females. The serum albumen was
above 3 g/I00 ml in all but one male patient, and the serum
transferrin was above 150 mg/l00 ml in all but 2 female patients,
thus giving no idea of their undernutrition. Our diet which rigidly
adheres to I g/kg/day of protein intake, without specifically stating
the daily calorie intake, does lead to undernutrition. Thus, not only
should our diets become more flexible, but also greater care should
be devoted to dietary explanation, and this should be regularly
checked with food histories.
Familial renal amyloidosis. E. MacSearraigh, D. North-Coombes,
and J. Kallmeyer. Renal Unit, Addington Hospital, Durban, Natal.
The world literature on familial amyloidosis is reviewed. Renal
involvement is specially considered. A new kindred of Anglo-
Saxon origin is discussed. The position vis a vis chronic hemo-
dialysis, renal transplantation, and therapy with colchicine is dis-
cussed.
Fungal infections in the post-transplant patient. A. M. Meyers,
M. Kraayenbrink, D. Sa/ant, F. J. Milne. R. Botha, and J. A.
Myburgh. Departments of Medicine and Surgery, University of the
Witwatersrand and Renal Unit, Johannesburg General Hospital,
Johannesburg. Eighteen fungal infections occurred in 16 out of2IO
posttransplant patients, an incidence of 7.6%. The mortality rate
was 56%. There were eight nocardial infections, five candida, three
cryptococcal, and two aspergillous infections. Bacterial sepsis oc-
curred in five patients and contributed to death in all five. In-
fections occurred early in 2/3rds (i.e., < 6 months posttransplant),
often with an identifiable precipitating cause, and late in another
1/3 (i.e., 3 or more yr posttransplant), usually without any precipi-
tating cause. Treatment of nocardial infections with antibiotics is
effective but must be lifelong. Withdrawal of antibiotics after 1½
and 2½ yr, respectively, in 2 patients resulted in cerebellar ab-
scesses in both. Vigorous treatment of cryptococcal fungemia and
meningitis in one patient has resulted in cure. Both intravenous
and intrathecal amphoterecin B were used together with 5-flu-
rocytosine, and the injections were monitored by serial blood and
CSF cryptococcal antigen titres. Treatment of candida lesions
when undertaken was unsuccessful and aspergillosis was only diag-
nosed post mortem. It is concluded that even in the compromised
host, early diagnosis and vigorous treatment, coupled with the
judicious minimization of immunosuppressive agents can result in
cure of the patient with salvage of renal function in a reasonable
proportion of cases.
Ionized calciums in renal and other metabolic osteodystrophies.
A. M. Meyers, L. Laidley, F. Levine, F. J. Mi/ne, D. Sa/ant, and A.
Kennedy. Departments of Medicine, Orthopaedics and Radiology,
Wit watersrand Medical School and Renal Unit, Johannesburg Gen-
eral Hospital. Ionized calciums have been measured in the follow-
ing groups: A = normals; B = patients on maintenance peritoneal
dialysis and C = patients on maintenance hemodialysis. A calcium
ion exchange electrode (Orion, model SS—20) was used, and all
measurements were done in duplicate. Results were correlated with
total calciums, phosphorus, alkaline phosphatase, circulating hy-
droxy-cholecalciferol levels, and serum proteins. These results were
further correlated with clinical parameters, photonabsorbtiometry,
and skeletal surveys, including xeroradiography. Bone biopsies for
histology and quantitative microradiography have been taken but
are not ready for comment. The mean ionized calcium was low in
group B. The levels were mainly normal in group C but in those
patients with "effective" secondary hyperparathyroidism as diag-
nosed clinically and radiologically, the levels were high in all
instances. Low ionized calciums were found in group C patients
who had undergone previous parathyroidectomy, sometimes in the
presence of normal total calciums. In another group (D), patients
with rheumatoid arthritis were studied. About 1/3 had high ion-
ized calciums which returned to normal after calcitonin therapy.
The significance of these findings are discussed.
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Candida infections in patients on maintenance peritoneal dialysis.
A. M. Meyers, P. Disler, K. Kay, C. Bloch, and K. I. Furman.
Departments of Medicine and Pharmacology. Witwatersrand Uni-
versity, Medical School, Microbacteriology S.A.I.M.R. and Renal
Unit, Johannesburg General Hospital. Four patients developed can-
dida infections while on maintenance peritoneal dialysis. Three
patients (one diabetic) had candida peritonitis, and the fourth
developed candidemia while receiving parenteral antibiotics for a
bacterial peritonitis. Severe abdominal pain in the absence of sys-
temic signs was the cardinal feature in the first three patients. The
patient with a catheter candidemia presented with shaking chills,
high fever, and evidence of a disseminated intravascular coagu-
lopathy. In one patient, a large intraperitoneal candida abscess was
drained. Three of the four patients were treated with 5-Flurocyto-
sine (5-FC) i.p. and amphoterecin B i.v. Two of these patients were
transferred to hemodialysis; oral 5-FC and parenteral amphotere-
cm therapy were continued in both. The fourth patient (with
diabetis mellitus) was not treated. Blood and both peritoneal and
hemodialysis dialysate of 5-FC levels and amphoterecin were mon-
itored continuously. While on peritoneal dialysis, 5-FC levels were
maintained at 50zgm/ml via continuous i.p. lavage, and no oral
supplements were necessary. On hemodialysis, 5-FC was cleared at
approximately the same rate as creatinine (i.e., 100 mI/mm on a
standard U.F. II coil dialyser), and oral supplements were neces-
sary. Amphoterecin B was not cleared at any significant rate during
either maintenance peritoneal dialysis or maintenance hemo-
dialysis. All three patients are alive three months after contracting
the infections. Two are completely cured, while the third is well
controlled. It is concluded that the combination of 5-FC and
amphotericin B are successful agents in the treatment of life threat-
ening candida infections in patients on maintenance peritoneal
dialysis.
Effect of age and exercise on the cardiac reflexes of healthy
hemodialysis patients. F. J. Mi/ne. A. Guz. K. Murphy, H. Purcell,
R. Jewkes, and H. E. de Wardener. Renal Unit, Johannesburg
General Hospital. When 12 healthy young (mean age, 29.7 yr;
range, 19 to 39) hemodialysis patients were compared to controls
(mean age, 29 yr), the patients had lower Valsalva ratios at rest.
With further subdivision of the groups according to age (19 to 29 yr
and 30 to 39 yr), the youngest dialysis group (N = 5) had similar
ratios to the youngest control group (N = 6), but the older dialysis
patients (N = 7) had strikingly lower ratios than their controls (N
= 6). This age-related change was confirmed in four patients who
were between 40 and 51 yr. The factors involved in the dispropor-
tionately lower ratios in the older dialysis group include longer
duration on dialysis, subclinical volume overload, and a higher
hemoglobin. However, although all groups had similar resting
blood pressures, the older two groups showed marked systolic
hypertension during dynamic exercise, and this exercise-induced
rise in blood pressure bore an inverse relation to the exercise heart
rate, suggesting that the baroreceptors were acting appropriately. It
is suggested the exercise hypertension seen especially in the older
groups is mediated by an abnormally high peripheral vascular
resistance consequent upon accelerated aging of the vascular tree.
When future studies of autonomic integrity are made, the variables
of age, volume status resting and exercise blood pressure, and
possibly exercise hemodynamics should be taken into consid-
eration.
Pathological picture of adult nephrotic syndrome at Tygerberg
Hospital. 0. 1. Oosthuizen and P. B. Marcus. Renal Unit. Tyger-
berg Hospital, Parowvallei. Fifty-seven cases of nephrotic yn-
drome in patients over the age of 12 yr are reviewed. The diagnosis
was based on generally accepted criteria. Their ages ranged from
12 to 70 yr, with most cases (37) occurring before the age of 30 yr.
Only two cases of true minimal change lesions were found.
Twenty-five cases had renal failure at the time of diagnosis. The
different pathologic pictures are briefly outlined and described:
Pathologic types: No. %
Mesangiocapillary glomerulonephritis
Mesangial proliferative
glomerulonephritis
Membranous nephropathy
Focal glomerulosclerosis
Resolving acute glomerulonephritis
Minimal change
Rapidly progressive glomerulonephritis
Systemic lupus erythematosus
Chronic pyelonephritis
Diabetic nephropathy
Experience with isoniazid hemodialysis (INH) in live patients with
membranoproliferative glomerulonephritis. F. H. Pauw. Department
of Internal Medicine, University of the Orange Free State, B/oem-
fontein. With the idea that INH might be useful as an immunosup-
pressive agent, we treated five patients with INH after a morpho-
logic diagnosis of membranoproliferative glomerulonephritis had
been made. Two patients showed no response and had progressive
deterioration in renal function. One died after a period of hemo-
dialysis. The other has marked hyalinization four years after the
diagnosis was made. Three patients seemed to improve. One of
these, who presented with nephrotic syndrome early in pregnancy
and had impaired renal function and hypocomplementemia, had
initially been diagnosed as membranoproliferative glomerulo-
nephritis. This diagnosis, however, was retrospectively revised to
preeclampsia. The other two cases, who seemed to improve, had
intramembranous deposits. After an initial period of abnormal
renal function, both have decreased urinary protein loss and have
sustained good renal function. None of the patients showed signs
of toxicity. None of the patients had evidence of tuberculosis.
These observations do not confirm therapeutic efficacy of INH in
membranoproliferative glomerulonephritis.
The influence of isoniazid (INH) therapy on lymphocyte sub-
populations. F. H. Pauw, F. P. Relief A. du P. 1-Jeyns, and D. J. van
der Berg. Departments of Medicine and Hematology, University of
Orange Free State, Bloemfontein. There is considerable evidence in
the literature that pyridoxine plays a role in the intact immune
system. Pyridoxine deficiency in animals have been shown to cause
reduced antibody response and delayed hypersensitivity. In human
disease abnormalities of immune phenomena have been found to
occur in some disease states which are also associated with bio-
chemical vitamin B6 deficiency. Dimunition of reactivity in mixed
lymphocyte cultures in uremics could be reversed by treating the
patients with vitamin B6 orally. The question arose whether a
vitamin B antagonist such as isoniazid (INH) could be used
therapeutically to influence the immune system. A previous study
indicated that INH did not alter percentage inhibition in the
Rosette Inhibition Test, although a change in the percentage of
lymphocytes forming rosettes with sheep-red cells was noted. INH,
900 mg daily, was given to an experimental person, and lym-
phocyte counts and the T—, B—, and null cells were determined by
the method of Pudifin. On the sixth day of therapy, there was a
marked reduction in I cells. B cells did not alter in response to
therapy. Null cells markedly increased on the seventh day of treat-
n3ent. The change in T and null cells were sustained for seven days,
when, on the third day after vitamin B6 had been added to the
regime, T cells increased and null cells decreased. Null cells did not
approach pretreatment values at this stage. These changes in lym-
phocyte subpopulations seem to be caused by INH therapy and
were partially reversed by adding vitamin B6 to therapy. It appears
as if the effect of INH was mediated through its well known
vitamin B6 antagonism.
17 29.8
13 22.8
8 14.0
6 10.5
3 5.3
2 3.5
1 1.8
3 5.3
2 3.5
2 3.5
57 100%Total
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Serum albumen lowers short-circuit current in toad skin: The
explanation of an effect previously attributed to natriuretic hormone.
D. Querido and L. C. lsaacson. Department Physiology, Medical
School, University of Cape Town. We are engaged in reexamining
the evidence for the existence of "natriuretic hormone." Nut-
bourne et al (C/in Sd 38:629, 1970) showed that expansion of a
dogs circulating blood volume induced a fall in PD and short-
circuit current (SCC) across a toad skin placed within the circula-
tion. They attributed this to the elaboration of a sodium transport.
inhibitor substance. The response was accompanied by a + 10%
rise in plasma protein concentration (unaccompanied by a rise in
Hct), presumably derived from the bovine albumen used to prime
their extracorporeal circuit. We have repeated their experiment,
using toad skins incorporated in the circulation of rats. Volume
expansion had no effect on PD of SCC (14 experiments) despite the
occurrence of the expected diuresis, kaliuresis, and natriuresis. We
are thus unable to confirm the observations ofNutbourne et al. We
then investigated the effects of albumen on SCC and PD across
isolated toad skin; each of four commerically available albumen
preparations tested (bovine & human), lowered SCC and PD. The
effect was maximal on skins bathed in hyposmotc Ringer's solu-
tion and much less marked on skins bathed in rat blood. The
findings suggest that the fall in SCC reported by Nutbourne et al
may have been mediated simply by the rise in plasma protein
concentration.
End stage renal failure and tuberous sclerosis. D. Rickards, E.
MacSearraigh, and J. Kallmeyer. Renal Unit, Addinglon Hospital,
Durban, Natal. Renal failure and tuberous sclerosis as rare syn-
dromes of reno-vascular neoplasms and systemic disease are re-
viewed. A 16 yr old patient is detailed and the rationale of dialysis
and/or transplantation is argued.
Ultrasonographic localization of the kidney for renal biopsy. D. J.
Salant, F. J. Mi/ne. W. Andrews, and A. M. Meyers. Renal Unit.
Johannesburg General Hospital, Johannesburg. Ultrasonography of
the kidney gives good structural definition and is, in itself, a very
useful diagnostic tool. We adopted the technique of ultrasono-
graphic localization of the kidney, using the Echoline scanner with
A and B modes, in those cases where renal biopsy was indicated
but in whom X-ray fluoroscopy was impossible because of poor
renal function for other reasons. The simplicity, accuracy of
localization, and low complication rate of the procedure in these
high risk cases have resulted in our using ultrasound as the tech-
nique of choice in the localization of the kidney for renal biopsy.
The results of our first 39 biopsies using this technique will be
presented. Renal tissue of diagnostic quality was obtained in 92%
of attempted biopsies. Perinephric bleeding requiring transfusion
occurred in three cases and was the most severe complication
encountered.
Renal tubular dysfunction in analgesic nephropathy. D. J. Salant,
M. Lewis, Leonor Laidley, Margeretha Viljoen, F. J. Milne, R.
Rabkin, and A. M. Meyers. Renal Unit, Johannesburg General
Hospital. It has been our clinical impression that patients with
analgesic nephropathy (AN) suffer from a tendency to acidosis and
an inability to concentrate their urine, which is disproportionate to
glomerular dysfunction. Results of a preliminary study appeared
to confirm this impression. Comprehensive one-day renal function
tests have been done in 21 patients with AN, 11 patients with a
variety of chronic nonanalgesic renal diseases (general renal fail-
ure-GRF), and 16 normal volunteers. Creatinine clearance (Ccr)
was reduced in all patients with AN and in all but one of those with
GRF. There was no evidence of a selective defect in proximal
tubular function in the group with AN. A defective urinary con-
centrating mechanism was found which was related to the reduc-
tion in Ccr in both study groups. However, this was shown to be
significantly more severe in the group with AN than in the group
with GRF, and this difference was particularly marked at higher
Ccr values. A urinary acidification defect was found in both the
AN and GRF groups. The defects in titratable acid and ammonia
(NH3) excretion in both groups of patients were shown to be the
result of a reduction in the functioning nephron mass as deter-
mined by the Ccr, with no significant difference between the
groups. In addition, the defect in NH3 excretion in many patients
from both groups was aggravated by a relatively alkaline urine. We
conclude that, while patients with AN are characterized by a
defective urinary concentrating mechanism, other aspects of renal
tubular function are similar to that of patients with other forms of
chronic renal disease.
Systemic lupus erythematosus in the Natal Black and Indian
patient. Y. K. Seedat. Department of Medicine, University of Natal,
Durban. This study consisted of 30 patients (17 Indian and 13
Black patients). Systemic lupus erythematosus (SLE), as judged
from the hospital admission data, appeared to be more common in
Indians than in the Black population group of Natal. The salient
clinical manifestations, the biochemical investigations, and the
clinical conditions that may be simulated by SLE were described.
Renal biopsy was done in 27 patients, and renal histologic changes
were present in 26 patients. The high incidence of renal in-
volvement may be because the patients presented at a late stage.
The presence of heavy albuminuria, low serum complement, and
raised blood urea correlated with severe renal histologic changes.
Tuberculosis is still a very common disease in the Black population
group, and various issues arose in connection with this. 1) The
development of tuberculosis as a complication of corticosteroid
therapy in an unduly high number (3/30) of our cases suggests that
routine INH prophylaxis is warranted, particularly if the tubercu-
lin skin is positive. 2) Patients presenting with serositis are usually
(and not unreasonably) considered to have tuberculosis; the diag-
nosis of SLE is therefore sometimes initially overlooked. 3) Despite
the very widespread use ofisoniazid in Blacks, we encountered no
case of drug-induced lupus erythematosus.
Care of the chronically ill African renal patient.Y. K. Seedat.
Department of Medicine, University of Natal and King Edward VIII
Hospital, Durban. The three major chronic renal diseases in the
African are hypertension, chronic renal failure, and nephrotic syn-
drome. The various therapeutic agents for the treatment of hyper-
tension are described. The most common histologic type of ne-
phrotic syndrome is the proliferative lesion, and therapy is
palliative with the use of diuretics. Chronic renal failure is treated
conservatively, and facilities for dialysis and renal transplantation
are very limited. Because of social, economic and cultural factors,
and poor follow-up of patients, the treatment of the chronically ill
African renal patient presents a major challenge to the clinician.
Renal failure in marathon runners. H. Schiff, E. MacSearraigh,
and J. Kallmeyer. Renal Unit, Addington Hospital, Durban, Natal.
Hemodialysis was performed for acute renal failure following
Rhabdomyolysis sustained after a 49 kilometer run on a very hot
day. The mechanism is discussed and detailed investigations were
performed. A South African survey reveals eight cases where
dialysis facilities were required. The cases are reviewed. Metabolic
profiles and myoglobin levels were done on 50 volunteers in the
Comrades Marathon. Views are expressed as to correct intake of
fluids and electrolytes.
Labetalol used as a hypotensive agent in the presence of renal
disease. F. D. Thompson, A. M. Joekes, and M. M. Hussein. In-
stitute of Urology, London University, and St. Peter's Group of
Hospitals. Prior toextensive use of labetalol as a hypotensive agent
in patients with renal impairment, the pharmacokinetics were es-
tablished using the tritiated labelled compound in two patients,
and the biochemical half-life was assessed in a further four patients
with severe functional impairment, using a chemical method of
analysis. The half-life of the parent compound in man is from
3½—4½ hr which, in the presence of renal failure, is not altered.
Fifteen patients were then given labetalol in a dose ranging from
150 to 2,400 mg/day in divided dose with a significant hypotensive
effect. Renal function was monitored by estimates of the plasma
creatinine and creatinine clearance. Some patients were followed
up to two years and others for a few months. With the long term
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patients, there was no significant reduction in either measurement,
although in a few patients a slight reduction in creatinine clearance
was seen.
Hemodynamic effects of intravenous labetalol compared with
propranolol, hydralazine, and diazoxide. F. D. Thompson and A. M.
Joekes. Institute of' Urology, London University, and St. Peter's
Group of Hospitals. Labetalol, I to 2 mg/kg of body wt, was given
to four hypertensive patients. Serial recordings of the blood pres-
sure, pulse rate, and cardiac output were made. Propranolol was
given i.v., 8 to 16mg, to a separate group of hypertensive subjects,
and following a reduction of the pulse rate, this same group was
given the peripheral dilator hydralazine, 20 mg iv. To a third
hypertensive group, the peripheral dilator diazoxide was given in a
dose of 300 mg iv. With labetalol there was a significant reduction
of both systolic and diastolic pressure without a significant second-
ary tachycardia or increase in the cardiac output. Propranolol
alone reduced the pulse rate and cardiac output without any signif-
icant hypotensive effect, but the blood pressure fell when hydrala-
zinc was added. With diazoxide a marked reduction in pressure
was achieved, but at the expense of a pronounced secondary tachy-
cardia and increase in the cardiac output, which may be harmful
to patients with underlying cardiac disease.
Prazosin (P) in the treatment of children with severe hypertension.
P. D. Thompson and M. V. Pokroy. Transvaal Memorial Hospital
for Children and University of the Witwatersrand. An open study to
evaluate the efficacy and toleration of P (Minipress) when added to
or replacing existing multiple medication in six children (4 to 15 yr)
with severe hypertension due to renal disease was undertaken. P
was commenced with a dosage of 2 to 3 mg/day, given in 3 divided
doses (60 to 100 mcg/kg/day), and the dose doubled if adequate
control had not been obtained after 4 weeks. Maximum doses were
10 to 14 mg/m2/day, e.g., 2mg three times a day in the 4 and 6 yr
olds, and duration of treatment was greater than one year in all six
patients. The mean lying systolic pressure fell from 145 to 128 mm
Hg and diastolic pressure fell from 101 to 88 mm Hg, but these
differences were not significant statistically. Similar results were
obtained with patients standing. Better control in blood pressure
was achieved in 4 to 8 weeks in all patients. Main side effects were:
sleepiness, four patients; dizziness, three; dry mouth and blocked
nose, one: and, after more than 8 months' treatment (and dosage of
> 10 mg/m2/day), a transient rise in SGOT in five patients and
similarly SGPT in four. Prazosin was withdrawn in only one pa-
tient (the 4-yr-old) because his parents gave him the tablets very ir-
regularly. One can conclude that P may be useful in combination in
the control of severe hypertension in childhood, and that the drug is
reasonably tolerated, but more experience in its use in children is
required.
Longterm follow-up of children with the hemolytic-uremic syn-
drome (HUS). P. D. Thompson, B. S. Kaplan, J. Marcus, A. Roth-
berg, and A. Olinsky. Transvaal Memorial Hospital for Children and
University of the Witwatersrand. In 1969, when the results of treat-
ment of patients with HUS were analyzed, the mortality rate was
thought to be unacceptably high. Patients were divided into two
groups prospectively from 1969: mildly affected (MA) infants who
were not anuric; severely affected (SA) infants who were anuric for
24 hr. All SA infants from 1969 onwards were managed with early
and frequent peritoneal dialysis. Water and electrolyte distur-
bances and hypertension were meticulously controlled in all MA
and SA patients; none were given steroids, heparin, or strepto-
kinasc. 44 patients (24 MA: 19 SA, and 1 6-year-old girl with an
inexorable course) have been treated. The mortality rate of the 44
patients was 4.5%. Compared to the results prior to August 1969,
the mortality rate in SA patients and in patients with an inexorable
decline in renal function decreased from 77 to 10% (P = <0.001).
None of the 63 mildly affected patients treated from 1962 to 1975
have died. Thirty-three patients have been followed at the Renal
Clinic, Transvaal Memorial Hospital, for 6 months to 6 yr after the
onset. None of the 18 MA patients have azotemia, hypertension or
proteinuria on follow-up. Three of 15 SA patients require antihy-
pertensive therapy. One has chronic renal failure with serum creati-
nine of 1.7 mg/dl and a urine protein excretion of 2.7 g/24 hr.
None of the 44 patients have significant neurologic or EEG abnor-
malities on follow-up.
A Case of sickle cell thalassemia associated with rapidly progres-
sive glomerulonephritis. Y. Variawa, J. Milne, H. Schneider, C.
Levin, A. Moti, and J. Lewis. Renal Unit, Johannesburg General
Hospital. Johannesburg. A patient with a known case of sickle cell-
thalassemia developed the nephrotic syndrome and progressive
renal failure over a four month period and has required mainte-
nance hemodialysis since. This was not accompanied by evidence
of streptococcal infection, SLE, significant papillary necrosis, or
renal vein thrombosis. Histologically there was mild mesangial in-
crease with 88% circumferential crescent formation: the prolifera-
tion was purely exocapillary. Only mild tubular and interstitial
changes were seen. The immunofluorescence studies showed no
positive staining. The patient has been on hemodialysis for six
months with none of the anticipated complications. Thus, rapidly
progressive glomerulonephritis may be a rare renal complication
of sickle cell thalassemia disease,
Chronic dialysis associated encephalopathy. N. Porkroy and G. N.
Thatcher, Renal Unit. Groote Sehuur Hospital and University of
('ape Town Medical School, Observatory, ('ape, South Africa. Re-
cently, a specific neurologic syndrome has been described by sev-
eral authors working with chronically dialyzed populations. This
unusual condition has been recognized in only a few isolated
dialysis units. Over the past four years we have been aware of an
identical syndrome in Cape Town. The majority of patients with
this syndrome have died. Currently it is the leading cause of death
in the Groote Schuur Unit. The syndrome, characterized by speech
abnormalities, dyspraxia of movement, asterixis, myoclonus, per-
sonality changes, disordered electroencephalograms, dementia,
psychosis, and convulsions, is almost invariably progressive. The
features seen in 13 patients in our unit are described and illustrated
by typical cases. We are the only Renal Service seeing the condition
in South Africa. Energetic therapy in the attempt to prevent bone
disease appears related to the incidence of this condition at our
hospital. Large amounts of aluminium binders were prescribed.
Mean predialysis blood phosphate in affected subjects was 3.7
mg/lOO ml and often below 2 mg/l00 nil, as opposed to non-
affected patients (mean 5.6 mg/l00 ml). Osteodystrophy was se-
vere in the cncephalopathy group with bone pain and multiple
fractures being prominent. Transplantation often precipitated'the
clinical manifestations. Three patients have had a stunted progres-
sion since a policy of stopping aluminum products has been in-
troduced. No positive evidence for an infective case has been
found. Aluminum retention or phosphate depletion or both might
be responsible for this encephalopathy. A vigorous attempt is
being made to transplant all patients before their chronic dialysis
life has reached 14 months.
